tradingkey.logo
tradingkey.logo
Pesquisar

Abbott Laboratories

ABT
Adicionar à lista de desejos
92.165USD
+1.425+1.57%
Fechamento 07/01, 16:00ETCotações atrasadas em 15 min
160.56BValor de mercado
25.58P/L TTM

Mais detalhes de Abbott Laboratories Empresa

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

Informações de Abbott Laboratories

Código da empresaABT
Nome da EmpresaAbbott Laboratories
Data de listagemApr 06, 2073
CEOFord (Robert B)
Número de funcionários114000
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 06
Endereço100 Abbott Park Road
CidadeABBOTT PARK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60064-3500
Telefone12246676100
Sitehttps://www.abbott.com
Código da empresaABT
Data de listagemApr 06, 2073
CEOFord (Robert B)

Executivos da empresa Abbott Laboratories

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.84K
-1.49%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.34K
+6.29%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
23.32K
+8.58%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
18.00K
+12.70%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.84K
-1.49%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%

Perguntas frequentes

Quem são os cinco principais acionistas de Abbott Laboratories?

Os cinco principais acionistas de Abbott Laboratories são: Mr. Daniel J. Starks

Quantas instituições possuem ações da Abbott Laboratories (ABT)?

Em 2026Q1, 4859 instituições possuíam ações da Abbott Laboratories, com valor de mercado aproximado de 1.25B, representando 71.75% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -187252308.00.

Qual é a maior fonte de receita da Abbott Laboratories?

Em 2026Q1, o segmento de negócios Diabetes Care gerou a maior receita para Abbott Laboratories, totalizando 8.00B e representando 18.04% da receita total.